PFCS
SGMT icon

Pale Fire Capital SE’s Sagimet Biosciences SGMT Stock Holding History

Pale Fire Capital SE’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Hold
221,875
– – 0.1% 29
2025
Q4 		$1.31M Buy
+221,875
New +$1.59M 0.09% 31
2025
Q2 		– Sell
-10,989
Closed -$35.8K – 70
2025
Q1 		$35.8K Sell
10,989
-7,321
-40% -$30.7K ﹤0.01% 61
2024
Q4 		$82.4K Buy
+18,310
New +$92.8K 0.02% 48

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pale Fire Capital SE's SGMT Position: Q1 2026 in Review

Pale Fire Capital SE held its Sagimet Biosciences (SGMT) position steady in Q1 2026 at 221,875 shares worth $1.16M. The position accounts for 0.1% of the portfolio, ranked #29.

Pale Fire Capital SE first reported a position in SGMT in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.31M in Q4 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Pale Fire Capital SE held 221,875 shares of Sagimet Biosciences worth $1.16M as of Q1 2026.
  • Pale Fire Capital SE left its Sagimet Biosciences share count unchanged in Q1 2026.
  • Sagimet Biosciences made up 0.1% of Pale Fire Capital SE's portfolio in Q1 2026, its #29 holding.
  • Pale Fire Capital SE first reported a position in Sagimet Biosciences in Q4 2024 and has held it in 4 quarters since.
  • Pale Fire Capital SE's Sagimet Biosciences position peaked at $1.31M in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Pale Fire Capital SE's 13F filing for Q1 2026, filed 14 May 2026.